Operationalizing diagnostic criteria for Alzheimer's disease and other age‐related cognitive impairment—Part 1
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
In this article, the challenges faced by several noted population studies for Alzheimer dementia in operationalizing current clinical diagnostic criteria for Alzheimer's disease (AD) have been reviewed. Differences in case ascertainment, methodological biases, cultural and educational influences on test performance, inclusion of special populations such as underrepresented minorities and the oldest old, and detection of the earliest symptomatic stages of underlying AD have been considered. Classification of Alzheimer dementia may be improved by the incorporation of biomarkers for AD if the sensitivity, specificity, and predictive value of the biomarkers are established and if they are appropriate for epidemiological studies, as may occur should a plasma biomarker be developed. Biomarkers for AD could also facilitate studies of the interactions of various forms of neurodegenerative disorders with cerebrovascular disease, resulting in “mixed dementia”.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physical Activity, All-Cause Mortality, and Longevity of College Alumni
Paffenbarger, R. S., Hyde, R., Wing, A. L., & Hsieh, C.-C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603063141003 · Cited by 2,742 · cited 1×
“Many risk factors for dementia in the young-old, such as diabetes and physical inactivity, also increase risk of death [82,83].”
BackgroundRoth, M., Tym, E., Mountjoy, C. Q., Huppert, F. A., Hendrie, H., Verma, S., & Goddard, R. (1986) · British Journal of Psychiatry · doi:10.1192/bjp.149.6.698 · Cited by 2,090 · cited 2×
“diagnostic assessment process, the instruments developed by the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) [88] as well as the informant portion of the Cambridge Mental Disorders of the Elderly Examination [89] were used, but they too underwent the same process of harmonization as the CSID.”
MethodSelf-citationMild Cognitive Impairment as a Clinical Entity and Treatment Target
Petersen, R. C., & Morris, J. C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1160 · Cited by 935
Self-citationAge, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900
Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993
Gu, K., Cowie, C. C., & Harris, M. I. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1138 · Cited by 881
Tang, M.-X. (1998) · JAMA · doi:10.1001/jama.279.10.751 · Cited by 771
Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
Perrin, R. J., Fagan, A. M., & Holtzman, D. M. (2009) · Nature · doi:10.1038/nature08538 · Cited by 702 · cited 1×
“, CSF assays of amyloid-beta [Ab42] and tau proteins; amyloid imaging) currently show great promise for the in vivo detection of AD pathology [120,121].”
BackgroundDeCarli, C., Massaro, J., Harvey, D., Hald, J., Tullberg, M., Au, R., Beiser, A., D’Agostino, R., & Wolf, P. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.05.004 · Cited by 680 · cited 1×
“The presence or absence of brain infarction on MRI was determined, on the basis of previously published protocol, from the size, location, and imaging characteristics of the lesion [7,8].”
MethodDementia diagnosis in developing countries: a cross-cultural validation study
Prince, M., Acosta, D., Chiu, H., Scazufca, M., & Varghese, M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12772-9 · Cited by 594
Fratiglioni, L., Viitanen, M., von Strauss, E., Tontodonati, V., Herlitz, A., & Winblad, B. (1997) · Neurology · doi:10.1212/wnl.48.1.132 · Cited by 556
Cited by
Han, X., Rozen, S., Boyle, S. H., Hellegers, C., Cheng, H., Burke, J. R., Welsh-Bohmer, K. A., Doraiswamy, P. M., & Kaddurah-Daouk, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021643 · Cited by 429
“Currently, the sensitivity and specificity of the clinical diagnosis of AD is quite low (approximately 80%; [9]) and the currently available central AD biomarkers (MRI volumetrics, FDG-PET, CSF assays) perform at similar accuracy levels [10,11].”
BackgroundSelf-citationNational estimates of the prevalence of Alzheimer's disease in the United States
Brookmeyer, R., Evans, D. A., Hebert, L., Langa, K. M., Heeringa, S. G., Plassman, B. L., & Kukull, W. A. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.11.007 · Cited by 399
Nelson, P. T., Head, E., Schmitt, F. A., Davis, P. R., Neltner, J. H., Jicha, G. A., Abner, E. L., Smith, C. D., Van Eldik, L. J., Kryscio, R. J., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0826-y · Cited by 365
Lin, P., Zhong, Y., Fillit, H. M., Chen, E., & Neumann, P. J. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14227 · Cited by 127
Seshadri, S., Beiser, A., Au, R., Wolf, P. A., Evans, D. A., Wilson, R. S., Petersen, R. C., Knopman, D. S., Rocca, W. A., Kawas, C. H., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.12.002 · Cited by 97
Metadata
- Authors
- Mayeux, R., Reitz, C., Brickman, A. M., Haan, M. N., Manly, J. J., Glymour, M. M., Weiss, C. C., Yaffe, K., Middleton, L., Hendrie, H. C., Warren, L. H., Hayden, K. M., Welsh‐Bohmer, K. A., Breitner, J. C. S., & Morris, J. C.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2011-01
- Volume
- 7
- Issue
- 1
- Pages
- 15-34
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2915777197
- Cited by
- 61
- References
- 26
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Operationalizing diagnostic criteria for Alzheimer's disease and other age‐related cognitive impairment—Part 1. https://app.cochat.ai/papers/10.1016/j.jalz.2010.11.005
- The paper
- Mayeux, R., Reitz, C., Brickman, A. M., Haan, M. N., Manly, J. J., Glymour, M. M., Weiss, C. C., Yaffe, K., Middleton, L., Hendrie, H. C., Warren, L. H., Hayden, K. M., Welsh‐Bohmer, K. A., Breitner, J. C. S., & Morris, J. C. (2011). Operationalizing diagnostic criteria for Alzheimer's disease and other age‐related cognitive impairment—Part 1. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2010.11.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.